Indian markets are likely to witness stock-specific action across telecom, railways, pharmaceuticals, healthcare, infrastructure, hospitality and manufacturing on Thursday as companies announce fresh order wins, US product launches, fundraising plans, leadership changes and major block deals.
Here's a look at the key stocks, which could be in focus today.
Telecom & Digital Infrastructure
HFCL bags Rs 2,666 crore order for BharatNet Phase III project
The company has won a contract from Rail Vikas Nigam Limited for the BharatNet Phase III project worth Rs 2,666.09 crore. This project is for the supply of telecom products, construction of an optical fibre network and maintenance of the infrastructure for a period of ten years.
RailTel wins disaster recovery infrastructure project
RailTel Corporation of India has received a Letter of Intent (LoI) worth Rs 52.57 crore from Director IT for building disaster recovery IT infrastructure. The project involves supply, installation, integration, commissioning and five years of operations and maintenance at a data centre of a MeitY-empanelled cloud service provider.
Railways & Infrastructure
RVNL gets railway bridge project worth Rs 968 crore
RVNL receives a Letter of Acceptance from East Coast Railway for an EPC contract worth Rs 967.92 crore. The project involves the construction of bridges for the third and fourth railway lines on the Bhadrak-Vizianagaram section, bolstering the company's healthy order book.
Infraprojects gets nod for issue of NCDs
Infraprojects has approved the issuance of non-convertible debentures (NCDs) of Rs 35 crore, along with a green shoe option of Rs 20 crore through private placement to meet its funding requirements. The company has approved issuance of up to 350 NCDs.
KNR Constructions completes share transfer
KNR Constructions has offloaded its remaining holding of 0.10% in KNR Ramagiri Infra to Indus Infra Trust. As a result of the transaction, KNR Ramagiri Infra has ceased to be a subsidiary of the company.
Pharmaceuticals & Healthcare
Lupin launches hypertension drug in the US
Lupin launches tablets (40 mg and 80 mg) in the United States following US FDA approval. It is a medicine for treatment of high blood pressure in adults. It is bioequivalent to Edarbi. Lupin said it is the only first-to-file applicant and qualifies for 180 days of generic drug exclusivity.
Apollo Hospitals resolves RBI proceedings
Apollo Hospitals Enterprises has paid Rs 17.8 crore under a compounding order issued by the Reserve Bank of India. The payment has been made and proceedings against the company have been closed by the RBI.
Gujarat Themis Biosyn expands overseas
Gujarat Themis Biosyn has incorporated a step-down subsidiary, Themis Biosyn, in Ireland as part of its international expansion strategy.
Auto, EV & Manufacturing
Endurance Technologies approves new Pune plant
Endurance Technologies has approved a capital expenditure of Rs 47.3 crore to set up a greenfield manufacturing facility in Pune. The plant will manufacture lithium battery packs with an expandable capacity of up to 35,000 units per month.
Balkrishna Industries appoints new CFO
Balkrishna Industries has appointed Saroj Kumar Khuntia as its chief financial officer with effect from June 18. The appointment follows the retirement of former CFO Madhusudan Bajaj.
Bosch Home Comfort promoter plans OFS
Promoter Bosch Global Software Technologies will sell up to a 7.97% stake in Bosch Home Comfort India through an Offer for Sale (OFS) on June 18-19. The floor price has been fixed at Rs 1,150 per share.
Renewable Energy & Defence
Waaree Renewable gets additional solar project order
Waaree Renewable Technologies has secured yet another order worth Rs 31 crores from a customer regarding an ongoing solar power plant project, increasing the total order to Rs 1,045 crores.
NIBE unveils the Garudastra system
During an Indian Army demonstration, defence equipment maker NIBE displayed its long-range, vehicle-mounted mortar system, Garudastra, which has GPS and laser-guided precision strike capabilities.
Hospitality
Lemon Tree Hotels ventures into Sri Ganganagar
Lemon Tree Hotels has launched a new property in Sri Ganganagar, Rajasthan. With Carnation Hotels managing the hotel, the number of Lemon Tree Hotels in the state would rise to 23.
Corporate Developments
Mahindra & Mahindra reduces stake in joint venture
Mahindra & Mahindra's stake in Mahindra Summit Agriscience has declined to 58.8% from 60% after Summit Agro International subscribed to additional shares.
Sterlite Technologies approves QIP fundraising
The board of directors of Sterlite Technologies has approved fund raising through QIP, but there has been no announcement from the company regarding the amount of shares to be issued under the program.
Gujarat Gas receives exchange approval
Gujarat Gas has received stock exchange approval for the allotment of 62.27 crore equity shares to eligible shareholders of Gujarat State Petroleum and Gujarat State Petronet.
Sumeet Industries declares rights issue
Sumeet Industries will issue rights shares at Rs 11.86 each in the ratio of eight shares for every 25 shares held by the eligible shareholders on June 12, 2026.
E2E Networks incorporates wholly owned subsidiary
E2E Networks has incorporated Sovcloud Technologies as a wholly owned subsidiary with an initial subscribed capital of 10,000 equity shares.
Apollo Micro Systems allots warrants
Apollo Micro Systems has allotted 3.8 crore warrants on a preferential basis, which are convertible into one equity share.
Bulk and Block Deals
DOMS Industries to divest promoter stake worth Rs 935 crore
Italian promoter FILA sold a 7% stake in DOMS Industries via block deals for Rs 935 crore. Domestic institutional investors like SBI Mutual Fund and Axis Mutual Fund bought a large chunk of the shares.
Corona Remedies sees huge institutional activity
Sepia Investments, which is a private equity investment firm, along with Anchor Partners, sold an approximate share of 7.3 percent of Corona Remedies worth around Rs. 777 crores. The buyers consist of HDFC Mutual Fund, Aditya Birla Sun Life Mutual Fund, Invesco Mutual Fund, Kotak Mahindra Mutual Fund, White Oak Capital and global institutional investors.
HDFC Life reduces stake in Finolex Industries
HDFC Life Insurance sold close to a 1.3% stake in Finolex Industries through block deals worth about Rs 137 crore.
Bazaar Style Retail records promoter stake sale
Garg Brothers sold a 1.14% stake in Baazar Style Retail through a block deal valued at nearly Rs 29 crore.
(Disclaimer: This article is for informational purposes only and should not be considered investment advice. The views, opinions, and recommendations expressed herein are those of the respective experts. Readers are advised to consult a qualified financial advisor before making any investment decisions.)
Brent Oil Outlook Cut: Goldman Sachs Lowers Q4 2026 Forecast To $80 On Supply Recovery

